Ekso Bionics Holdings, Inc.
EKSO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $184,473 | $520,013 | $231,372 | $484,672 |
| - Cash | $6,493 | $8,638 | $20,525 | $40,406 |
| + Debt | $5,983 | $7,168 | $7,505 | $2,222 |
| Enterprise Value | $183,963 | $518,543 | $218,352 | $446,488 |
| Revenue | $17,925 | $18,279 | $12,912 | $11,246 |
| % Growth | -1.9% | 41.6% | 14.8% | – |
| Gross Profit | $9,511 | $9,079 | $6,214 | $6,749 |
| % Margin | 53.1% | 49.7% | 48.1% | 60% |
| EBITDA | -$9,453 | -$13,198 | -$14,037 | -$9,090 |
| % Margin | -52.7% | -72.2% | -108.7% | -80.8% |
| Net Income | -$11,330 | -$15,198 | -$15,080 | -$9,764 |
| % Margin | -63.2% | -83.1% | -116.8% | -86.8% |
| EPS Diluted | -0.56 | -1.1 | -1.16 | -0.88 |
| % Growth | 49.1% | 5.2% | -31.8% | – |
| Operating Cash Flow | -$9,846 | -$12,054 | -$14,688 | -$11,156 |
| Capital Expenditures | -$37 | -$157 | -$194 | -$59 |
| Free Cash Flow | -$9,883 | -$12,211 | -$14,882 | -$11,215 |